PHOENIX, Feb. 7, 2013 /PRNewswire/ --EastBridge Investment Group Corporation (EBIG), a provider of financial consulting services to companies in Asia and the United States ("EBIG"), today announced that on February 6, EBIG and Cellular Biomedicine Group ("CBMG") executed all documentation and filed the Articles of Merger with the Registry of Corporate Affairs of the British Virgin Islands with respect to the consummation of the merger of CBMG with CBMG Acquisition Limited, a wholly-owned subsidiary of EBIG. The merged company is a wholly-owned subsidiary of EBIG. EBIG continues to operate under the corporate name "EastBridge Investment Group Corporation", a Delaware corporation, and its common stock continues to be quoted on the OTCQB under stock symbol "EBIGD".
A shareholder conference call is scheduled for February 8, 2013, at 11:00am EST, for questions and answers with the new corporate management team of EastBridge. Dial-in numbers for both domestic and international calls are listed below. You may also listen to a replay of the conference call by dialing the appropriate number and access code below. A replay of the conference call will be available on the company's website following the call.
Participants Dial-In Numbers
Toll-Free (US & Canada) (888) 390-3983
International (201) 604-5105
Dialing In For Conference Recording Playback
1. Dial 888-632-8973, or 585-295-6791 if you are calling from outside the USA.
2. At the system prompt, dial your replay code (80529152) followed by the # sign.
About Cellular Biomedicine Group
Cellular Biomedicine Group, Ltd. develops proprietary cell therapies for
|SOURCE EastBridge Investment Group Corporation|
Copyright©2012 PR Newswire.
All rights reserved